Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,165,808
-
Total 13F shares
-
6,725,410
-
Share change
-
+6,338,792
-
Total reported value
-
$172,103,401
-
Price per share
-
$26.75
-
Number of holders
-
39
-
Value change
-
+$161,930,701
-
Number of buys
-
36
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2014
As of 31 Dec 2014,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,725,410 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Visium Asset Management, LP, EcoR1 Capital, LLC, JENNISON ASSOCIATES LLC, Redmile Group, LLC, BRIDGER MANAGEMENT, LLC, BlackRock Fund Advisors, JPMORGAN CHASE & CO, and VANGUARD GROUP INC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.